Joan D. Ellis

1.5k total citations
19 papers, 483 citations indexed

About

Joan D. Ellis is a scholar working on Molecular Biology, Infectious Diseases and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Joan D. Ellis has authored 19 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Infectious Diseases and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Joan D. Ellis's work include HIV Research and Treatment (3 papers), HIV/AIDS drug development and treatment (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Joan D. Ellis is often cited by papers focused on HIV Research and Treatment (3 papers), HIV/AIDS drug development and treatment (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Joan D. Ellis collaborates with scholars based in United States, United Kingdom and Japan. Joan D. Ellis's co-authors include John D. Gilbert, Rita A. Halpin, Timothy Olah, Lixia Jin, Sethu Sankaranarayanan, Craig A. Coburn, Adam J. Simon, Eric A. Price, Shawn J. Stachel and Kamlesh P. Vyas and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Joan D. Ellis

19 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joan D. Ellis United States 14 132 129 98 81 71 19 483
Naotoshi Yamamura Japan 11 119 0.9× 157 1.2× 90 0.9× 17 0.2× 116 1.6× 35 479
Robert A. Carr United States 19 41 0.3× 193 1.5× 92 0.9× 65 0.8× 191 2.7× 41 986
Paola Caria Italy 15 73 0.6× 182 1.4× 69 0.7× 50 0.6× 75 1.1× 44 604
Anne Cooper United Kingdom 13 59 0.4× 155 1.2× 29 0.3× 48 0.6× 211 3.0× 20 724
Susanne Gustavsson Sweden 11 248 1.9× 150 1.2× 81 0.8× 86 1.1× 36 0.5× 15 705
Anne Wu United States 13 79 0.6× 206 1.6× 131 1.3× 16 0.2× 78 1.1× 19 651
Maria de Jesus Perry Portugal 16 108 0.8× 212 1.6× 163 1.7× 133 1.6× 48 0.7× 34 734
Kevin N. Dack United Kingdom 12 59 0.4× 260 2.0× 114 1.2× 48 0.6× 99 1.4× 22 683
Steven Hansel United States 14 122 0.9× 200 1.6× 160 1.6× 91 1.1× 166 2.3× 29 683
Sangeeta Raje United States 15 54 0.4× 203 1.6× 70 0.7× 32 0.4× 122 1.7× 26 535

Countries citing papers authored by Joan D. Ellis

Since Specialization
Citations

This map shows the geographic impact of Joan D. Ellis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joan D. Ellis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joan D. Ellis more than expected).

Fields of papers citing papers by Joan D. Ellis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joan D. Ellis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joan D. Ellis. The network helps show where Joan D. Ellis may publish in the future.

Co-authorship network of co-authors of Joan D. Ellis

This figure shows the co-authorship network connecting the top 25 collaborators of Joan D. Ellis. A scholar is included among the top collaborators of Joan D. Ellis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joan D. Ellis. Joan D. Ellis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Sandhu, Punam, Junghoon Lee, Jeanine Ballard, et al.. (2016). P4‐036: Pharmacokinetics and Pharmacodynamics to Support Clinical Studies of MK‐8719: an O‐Glcnacase Inhibitor for Progressive Supranuclear Palsy. Alzheimer s & Dementia. 12(7S_Part_21). 20 indexed citations
2.
Uchida, Takuro, Nobuhiko Hiraga, Michio Imamura, et al.. (2015). Elimination of HCV via a non-ISG-mediated mechanism by vaniprevir and BMS-788329 combination therapy in human hepatocyte chimeric mice. Virus Research. 213. 62–68. 7 indexed citations
3.
Flattery, Amy, Emily Hickey, Charles Gill, et al.. (2011). Efficacy of Caspofungin in a Juvenile Mouse Model of Central Nervous System Candidiasis. Antimicrobial Agents and Chemotherapy. 55(7). 3491–3497. 14 indexed citations
4.
Tang, Cuyue, Yuhsin Kuo, Nicole T. Pudvah, et al.. (2009). Effect of P-glycoprotein-mediated efflux on cerebrospinal fluid concentrations in rhesus monkeys. Biochemical Pharmacology. 78(6). 642–647. 14 indexed citations
5.
Melamed, Jeffrey Y., Melissa S. Egbertson, Sándor Varga, et al.. (2008). Synthesis of 5-(1-H or 1-alkyl-5-oxopyrrolidin-3-yl)-8-hydroxy-[1,6]-naphthyridine-7-carboxamide inhibitors of HIV-1 integrase. Bioorganic & Medicinal Chemistry Letters. 18(19). 5307–5310. 20 indexed citations
6.
Wai, John, Bo Young Kim, Thorsten E. Fisher, et al.. (2007). Dihydroxypyridopyrazine-1,6-dione HIV-1 integrase inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(20). 5595–5599. 21 indexed citations
7.
Sankaranarayanan, Sethu, Eric A. Price, Guoxin Wu, et al.. (2007). In Vivo β-Secretase 1 Inhibition Leads to Brain Aβ Lowering and Increased α-Secretase Processing of Amyloid Precursor Protein without Effect on Neuregulin-1. Journal of Pharmacology and Experimental Therapeutics. 324(3). 957–969. 83 indexed citations
8.
Stachel, Shawn J., Craig A. Coburn, Sethu Sankaranarayanan, et al.. (2006). Macrocyclic Inhibitors of β-Secretase:  Functional Activity in an Animal Model. Journal of Medicinal Chemistry. 49(21). 6147–6150. 67 indexed citations
9.
Wong, Bradley K., Deborah Defeo-Jones, Raymond E. Jones, et al.. (2001). PSA-specific and non-PSA-specific conversion of a PSA-targeted peptide conjugate of doxorubicin to its active metabolites.. PubMed. 29(3). 313–8. 42 indexed citations
10.
Vyas, Kamlesh P., Rita A. Halpin, Leslie A. Geer, et al.. (2000). Disposition and Pharmacokinetics of the Antimigraine Drug, Rizatriptan, in Humans. Drug Metabolism and Disposition. 28(1). 89–95. 46 indexed citations
11.
Vickers, S., Anthony D. Theoharides, Byron H. Arison, et al.. (1999). In Vitro and In Vivo Studies on the Metabolism of Tirofiban. Drug Metabolism and Disposition. 27(11). 1360–1366. 32 indexed citations
12.
Ellis, Joan D., Elizabeth Hand, & John D. Gilbert. (1997). Use of LC-MS/MS to cross-validate a radioimmunoassay for the fibrinogen receptor antagonist, Aggrastat (tirofiban hydrochloride) in human plasma. Journal of Pharmaceutical and Biomedical Analysis. 15(5). 561–569. 13 indexed citations
13.
Prueksaritanont, Thomayant, Maria T. Stranieri, Elizabeth Hand, et al.. (1997). Effects of pentobarbital on pharmacokinetics and pharmacodynamics of a potent fibrinogen receptor antagonist, L-734 217, in dogs. Biopharmaceutics & Drug Disposition. 18(8). 649–663. 3 indexed citations
14.
Prueksaritanont, Thomayant, Lynn M. Gorham, Joan D. Ellis, et al.. (1996). Species and organ differences in first-pass metabolism of the ester prodrug L-751,164 in dogs and monkeys. In vivo and in vitro studies.. Drug Metabolism and Disposition. 24(11). 1263–1271. 6 indexed citations
15.
Frier, M., Joan D. Ellis, & M. Aslam. (1996). Stability of radiopharmaceuticals during administration to the intensive care patient. Journal of Clinical Pharmacy and Therapeutics. 21(3). 149–153. 2 indexed citations
16.
Olah, Timothy, et al.. (1996). Quantitation of the 5HT1D agonists MK-462 and sumatriptan in plasma by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry. Journal of Chromatography A. 726(1-2). 115–124. 49 indexed citations
17.
Prueksaritanont, Thomayant, Suresh K. Balani, Joan D. Ellis, et al.. (1995). Species differences in the metabolism of a potent HIV-1 reverse transcriptase inhibitor L-738,372. In vivo and in vitro studies in rats, dogs, monkeys, and human.. Drug Metabolism and Disposition. 23(7). 688–695. 12 indexed citations
18.
Gilbert, John D., Thomas Greber, Joan D. Ellis, et al.. (1995). The development and cross-validation of methods based on radioimmunoassay and LC/MS-MS for the quantification of the Class III antiarrhythmic agent, MK-0499, in human plasma and urine. Journal of Pharmaceutical and Biomedical Analysis. 13(8). 937–950. 16 indexed citations
19.
Barrett, Jeffrey S., Robert J. Gould, Joan D. Ellis, et al.. (1994). Pharmacokinetics and Pharmacodynamics of L-703,014, a Potent Fibrinogen Receptor Antagonist, After Intravenous and Oral Administration in the Dog. Pharmaceutical Research. 11(3). 426–431. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Naotoshi Yamamura Breakdown of academic impact, for papers by Robert A. Carr Breakdown of academic impact, for papers by Paola Caria Breakdown of academic impact, for papers by Anne Cooper Breakdown of academic impact, for papers by Susanne Gustavsson Breakdown of academic impact, for papers by Anne Wu Breakdown of academic impact, for papers by Maria de Jesus Perry Breakdown of academic impact, for papers by Kevin N. Dack Breakdown of academic impact, for papers by Steven Hansel Breakdown of academic impact, for papers by Sangeeta Raje
Rankless by CCL
2026